Clinical Trial Update: Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma [NA]

View source ↗

Summary

Clinical trial update for the Cilioscleral Interposition Device SV22 in primary open-angle glaucoma and angle-closure glaucoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angle-closure Glaucoma
• Open-angle Glaucoma

Snippet

Sponsor: Ciliatech | Conditions: Glaucoma, Open-Angle, Glaucoma, Narrow Angle | NA | Status: COMPLETED